TFRC and cancer: In SIRT3-deficient cells, the heightened production of ROS enhances IRP1’s binding affinity to IREs, leading to the aberrant upregulation of iron-related genes such as the transferrin receptor (TfR1), which governs iron uptake and promotes cancer cell proliferation.